Skip to main content

Calyxt, Inc. (CLXT)

NASDAQ: CLXT · Delayed Price · USD
2.43
-0.06 (-2.41%)
At close: Dec 8, 2021 4:00 PM
2.48
0.05 (2.06%)
After-hours:Dec 8, 2021 4:50 PM EST
Market Cap93.57M
Revenue (ttm)37.97M
Net Income (ttm)-35.54M
Shares Out38.51M
EPS (ttm)-0.96
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume218,473
Open2.48
Previous Close2.49
Day's Range2.43 - 2.59
52-Week Range2.18 - 12.43
Beta1.84
AnalystsBuy
Price Target7.63 (+214.0%)
Earnings DateNov 4, 2021

About CLXT

Calyxt, Inc., a technology company, focuses on delivering plant-based solutions in the United States. It engages in the development of improved digestibility alfalfa; high fiber wheat; high oleic low linolenic soybeans; winter oats; hemp; fat soybeans; and cold storable potatoes. As of March 4, 2021, the company had nine projects at Phase I stage or later in development across alfalfa, hemp, oats, soybeans, and wheat. Calyxt, Inc. has a research collaboration with NRGene, which includes the adoption of NRGene's cloud-based genomics platform to ...

IndustryBiotechnology
IPO DateJul 20, 2017
Employees59
Stock ExchangeNASDAQ
Ticker SymbolCLXT
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 7 analysts, the average rating for Calyxt stock is "Buy." The 12-month stock price forecast is 7.63, which is an increase of 213.99% from the latest price.

Price Target
$7.63
(213.99% upside)
Analyst Consensus: Buy

News

Calyxt Identifies More Than 15,000 Unique Chemical Signatures in Lab-Scale BioFactory™ Production Run

ROSEVILLE, Minn., Dec. 8, 2021 /PRNewswire/ -- Calyxt, Inc.  (Nasdaq: CLXT), a plant-based synthetic biotechnology company, today announced the completion of a key milestone in its lab-scale BioFactory™...

23 hours ago - PRNewsWire

Calyxt Announces Strategic Hires in AI/ML and Technology Licensing

ROSEVILLE, Minn., Dec. 6, 2021 /PRNewswire/ --  Calyxt, Inc.  (Nasdaq: CLXT), a plant-based synthetic biotechnology company, today announced the hiring of two senior roles important to furthering Calyxt...

2 days ago - PRNewsWire

Calyxt to Present at the 2021 Canaccord Genuity AgriFood Tech Innovation Virtual Forum

ROSEVILLE, Minn., Nov. 23, 2021 /PRNewswire/ --  Calyxt, Inc.  (Nasdaq: CLXT), a plant-based synthetic biotechnology company, today announced that management will present at the 2021 Canaccord Genuity A...

2 weeks ago - PRNewsWire

Calyxt (CLXT) Reports Q3 Loss, Tops Revenue Estimates

Calyxt (CLXT) delivered earnings and revenue surprises of -26.32% and 69.48%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

Calyxt Reports Third Quarter 2021 Financial Results

ROSEVILLE, Minn., Nov. 4, 2021 /PRNewswire/ --  Calyxt, Inc.  (NASDAQ: CLXT), a plant-based synthetic biotechnology company, today announced financial results for its third quarter ended September 30, 2...

1 month ago - PRNewsWire

5 Penny Stocks To Buy According To Analysts & Price Targets Up To 175%

Some of the best penny stocks 2021 has offered were some of… The post 5 Penny Stocks To Buy According To Analysts & Price Targets Up To 175% appeared first on Penny Stocks to Buy, Picks, News and Inform...

Other symbols:CCOCHEKGERNKULR
1 month ago - PennyStocks

Will Calyxt (CLXT) Report Negative Earnings Next Week? What You Should Know

Calyxt (CLXT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 month ago - Zacks Investment Research

Calyxt to Host third Quarter 2021 Financial Results Conference Call on Thursday, November 4, 2021, at 4:30 p.m. Easte...

ROSEVILLE, Minn., Oct. 19, 2021 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT) will hold a conference call on Thursday, November 4, 2021, at 4:30 p.m.

1 month ago - PRNewsWire

Calyxt Names IBM's Global Chief Artificial Intelligence Officer, Dr. Seth Dobrin, to Scientific Advisory Board

ROSEVILLE, Minn., Oct. 12, 2021 /PRNewswire/ --  Calyxt, Inc.  (Nasdaq: CLXT), a plant-based synthetic biotechnology company, today announced the appointment of Seth Dobrin, Ph.D.

1 month ago - PRNewsWire

Calyxt Announces New Strategic Direction to Provide Sustainable, Plant-Based Synthetic Biology Solutions to Expanded ...

ROSEVILLE, Minn., Oct. 5, 2021 /PRNewswire/ --  Calyxt, Inc.  (Nasdaq: CLXT), a plant-based synthetic biotechnology company, today announced the launch of a strategic initiative that will focus the Comp...

2 months ago - PRNewsWire

Calyxt Seeks To Develop Palm Oil Alternative

Calyxt Inc (NASDAQ: CLXT) has entered into a research collaboration with a food ingredient manufacturer based in Asia to develop an improved soybean to produce oil as a commercial alternative to palm oi...

2 months ago - Benzinga

Calyxt Announces Collaboration with Leading Global Food Ingredient Manufacturer to Develop Palm Oil Alternative

ROSEVILLE, Minn., Sept. 28, 2021 /PRNewswire/ --  Calyxt, Inc.  (Nasdaq: CLXT), a plant-based technology platform company, today announced it entered into a research collaboration with a leading global ...

2 months ago - PRNewsWire

Calyxt to Present at the H.C Wainwright 23rd Annual Global Investment Conference

ROSEVILLE, Minn., Sept. 7, 2021 /PRNewswire/ -- Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology platform company, today announced that a presentation given by management at the H.C Wainwright 23rd...

3 months ago - PRNewsWire

5 Penny Stocks Insiders Are Buying

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overa...

Other symbols:AMPYBXRXRSLS
3 months ago - Benzinga

Calyxt (CLXT) Reports Q2 Loss, Tops Revenue Estimates

Calyxt (CLXT) delivered earnings and revenue surprises of -10.53% and 50.00%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

4 months ago - Zacks Investment Research

Calyxt: Q2 Earnings Insights

Shares of Calyxt (NASDAQ:CLXT) rose in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 36.36% over the past year to ($0.21), which missed the est...

4 months ago - Benzinga

Calyxt Reports Second Quarter 2021 Financial Results

ROSEVILLE, Minn., Aug. 5, 2021 /PRNewswire/ --  Calyxt, Inc.  (NASDAQ: CLXT), a plant-based technology company, today announced financial results for its second quarter ended June 30, 2021.

Other symbols:SANW
4 months ago - PRNewsWire

Calyxt to Present at the Canaccord Genuity 41st Annual Growth Conference on August 11, 2021

ROSEVILLE, Minn., Aug. 4, 2021 /PRNewswire/ --  Calyxt, Inc.  (Nasdaq: CLXT), a plant-based biotechnology platform company, today announced that management will present at the Canaccord Genuity 41st Ann...

4 months ago - PRNewsWire

Calyxt (CLXT) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Calyxt (CLXT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

4 months ago - Zacks Investment Research

Calyxt Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

ROSEVILLE, Minn., July 27, 2021 /PRNewswire/ -- Calyxt, Inc.  (NASDAQ: CLXT), a plant-based biotechnology platform company, today announced that, in accordance with the offer letter entered into on July...

4 months ago - PRNewsWire

Calyxt to Host Second Quarter 2021 Financial Results Conference Call on Thursday, August 5, 2021 at 4:30 p.m. Eastern...

ROSEVILLE, Minn., July 19, 2021 /PRNewswire/ --  Calyxt, Inc.  (NASDAQ: CLXT) will hold a conference call on Thursday, August 5, 2021 at 4:30 p.m.

4 months ago - PRNewsWire

Calyxt Appoints Michael A. Carr As CEO

Biotechnology company Calyxt Inc (NASDAQ: CLXT) has appointed Michael A. Carr as President and Chief Executive Officer, effective July 27, 2021.

4 months ago - Benzinga

Calyxt Appoints Michael A. Carr as Chief Executive Officer

ROSEVILLE, Minn., July 15, 2021 /PRNewswire/ -- Calyxt, Inc.  (NASDAQ: CLXT), a plant-based biotechnology platform company, today announced the appointment of Michael A.

4 months ago - PRNewsWire

Calyxt Announces Expansion of Hemp Breeding Platform with Seedless Hemp Innovation

Triploid Breeding Process is Calyxt's Second Announced Advancement and Part of a Comprehensive Approach to Improving Hemp Genetics ROSEVILLE, MN / ACCESSWIRE / July 8, 2021 / Calyxt, Inc. (NASDAQ:CLXT),...

5 months ago - Accesswire

The Top 7 Gene-Editing Stocks to Buy for the Biggest Scientific Breakthrough of the Century

Doudna's breakthrough in CRISPR has since ushered in a new era of genetic engineering, making these the best gene-editing stocks to buy. The post The Top 7 Gene-Editing Stocks to Buy for the Biggest Sci...

5 months ago - InvestorPlace